We've seen this pattern with other widely adopted medications throughout history
However, they are legal under federal law and can be significantly less expensive than brand-name alternatives
(2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) This article was reviewed and approved by Lujain Alhassan, Bariatric Nutritionist, and Alice Fletcher, Lead Bariatric Dietitian, on 7 July 2025
doi: 10.1111/dom.14843, 53 GibbonsC.BlundellJ.Tetens HoffS.DahlK.BauerR.BaekdalT
Reducing the recruitment of -arrestin and the residence time of the ligand towards the receptor, thus decreasing internalization, is presumably the key of incretin drugs
[5] Active trial registrations can be found on ClinicalTrials.gov by searching for retatrutide or LY3437943